Disclosure vs. Deception: What the Similac Decision Means for Consumer Brands
A recent federal court decision rejecting a consumer’s claims concerning a popular infant formula provides an important reminder about the challenges inherent in prosecuting omission-based claims.
In Huggins v. Abbott Laboratories, the Northern District of Illinois dismissed claims alleging that the manufacturer misled consumers by failing to disclose the presence of heavy metals in the infant formula. The court found that plaintiffs failed to prove that reasonable consumers would interpret the product packaging as representing the absence of such substances.
The Court’s reasoning is important: Consumer protection claims are typically not based on what a company could have said. They are based on what a reasonable consumer would understand is communicated from the product packaging.
For businesses — particularly those operating in highly scrutinized consumer sectors such as health-related consumables — the decision reinforces that omission theories require a clear and unmistakable communication from consumer-facing messaging.
However, with litigation remaining robust in these areas, companies should consider this case as an opportunity to examine and refine their own disclosure strategies, not relax them.
The strongest defense for a manufacturer is not simply compliance; it is accuracy, transparency, and clarity in how products are described, marketed, and understood by the consumer.
Case Reference:
Huggins et al. v. Abbott Laboratories, No. 1:25-cv-02460 (N.D. Ill. Apr. 2026)
